TuHURA Biosciences (HURA) Competitors $2.30 -0.22 (-8.73%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.42 +0.13 (+5.43%) As of 07/11/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock HURA vs. PRTC, MBX, TRML, RZLT, ERAS, TECX, SLDB, ITOS, ETON, and ALTShould you be buying TuHURA Biosciences stock or one of its competitors? The main competitors of TuHURA Biosciences include PureTech Health (PRTC), MBX Biosciences (MBX), Tourmaline Bio (TRML), Rezolute (RZLT), Erasca (ERAS), Tectonic Therapeutic (TECX), Solid Biosciences (SLDB), iTeos Therapeutics (ITOS), Eton Pharmaceuticals (ETON), and Altimmune (ALT). These companies are all part of the "pharmaceutical products" industry. TuHURA Biosciences vs. Its Competitors PureTech Health MBX Biosciences Tourmaline Bio Rezolute Erasca Tectonic Therapeutic Solid Biosciences iTeos Therapeutics Eton Pharmaceuticals Altimmune TuHURA Biosciences (NASDAQ:HURA) and PureTech Health (NASDAQ:PRTC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Does the media prefer HURA or PRTC? In the previous week, PureTech Health had 3 more articles in the media than TuHURA Biosciences. MarketBeat recorded 4 mentions for PureTech Health and 1 mentions for TuHURA Biosciences. TuHURA Biosciences' average media sentiment score of 1.89 beat PureTech Health's score of 0.47 indicating that TuHURA Biosciences is being referred to more favorably in the media. Company Overall Sentiment TuHURA Biosciences Very Positive PureTech Health Neutral Which has preferable valuation and earnings, HURA or PRTC? PureTech Health has higher revenue and earnings than TuHURA Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTuHURA BiosciencesN/AN/A-$21.68MN/AN/APureTech Health$4.83M87.53$27.78MN/AN/A Do analysts recommend HURA or PRTC? TuHURA Biosciences currently has a consensus price target of $12.67, suggesting a potential upside of 450.72%. PureTech Health has a consensus price target of $45.00, suggesting a potential upside of 155.68%. Given TuHURA Biosciences' higher possible upside, equities research analysts plainly believe TuHURA Biosciences is more favorable than PureTech Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TuHURA Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Do institutionals and insiders have more ownership in HURA or PRTC? 0.6% of TuHURA Biosciences shares are held by institutional investors. Comparatively, 0.0% of PureTech Health shares are held by institutional investors. 0.2% of TuHURA Biosciences shares are held by company insiders. Comparatively, 5.3% of PureTech Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is HURA or PRTC more profitable? TuHURA Biosciences' return on equity of 291.69% beat PureTech Health's return on equity.Company Net Margins Return on Equity Return on Assets TuHURA BiosciencesN/A 291.69% 122.09% PureTech Health N/A N/A N/A Which has more risk & volatility, HURA or PRTC? TuHURA Biosciences has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. SummaryTuHURA Biosciences beats PureTech Health on 7 of the 13 factors compared between the two stocks. Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HURA vs. The Competition Export to ExcelMetricTuHURA BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$100.46M$2.94B$5.55B$9.09BDividend YieldN/A2.45%5.07%4.03%P/E RatioN/A10.0322.7821.11Price / SalesN/A292.01432.0899.75Price / CashN/A41.0526.2427.98Price / Book6.767.638.125.50Net Income-$21.68M-$55.05M$3.19B$250.38M7 Day Performance-6.88%8.43%3.62%4.79%1 Month Performance-6.50%8.14%5.98%9.59%1 Year PerformanceN/A1.62%29.39%16.41% TuHURA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HURATuHURA Biosciences1.6506 of 5 stars$2.30-8.7%$12.67+450.7%N/A$100.46MN/A0.00N/APRTCPureTech Health2.5049 of 5 stars$18.01flat$45.00+149.9%-26.3%$432.58M$4.83M0.00100News CoverageMBXMBX Biosciences1.7097 of 5 stars$12.88+3.3%$37.50+191.1%N/A$430.50MN/A0.0036Positive NewsGap DownTRMLTourmaline Bio2.0575 of 5 stars$15.96-2.8%$49.33+209.1%+20.6%$421.76MN/A-4.9744Positive NewsRZLTRezolute2.5724 of 5 stars$4.98+3.3%$11.83+137.6%+11.9%$412.20MN/A-4.3340News CoverageHigh Trading VolumeERASErasca3.3468 of 5 stars$1.42-1.4%$4.57+221.9%-51.2%$407.93MN/A-2.29120News CoverageTECXTectonic Therapeutic2.6227 of 5 stars$20.78-2.6%$83.60+302.3%+33.6%$398.47MN/A-2.84120Gap DownSLDBSolid Biosciences3.1412 of 5 stars$4.91-2.4%$15.10+207.5%-33.5%$389.90M$8.09M-1.64100News CoverageGap DownITOSiTeos Therapeutics3.3066 of 5 stars$10.07-1.1%$15.86+57.5%-36.3%$389.63M$35M-3.3190ETONEton Pharmaceuticals1.9709 of 5 stars$14.39-0.4%$29.67+106.2%+324.9%$387.51M$39.01M-79.9420ALTAltimmune2.2272 of 5 stars$4.43-6.9%$19.00+328.9%-47.6%$386.07M$20K-3.5250News CoverageAnalyst Forecast Related Companies and Tools Related Companies PRTC Competitors MBX Competitors TRML Competitors RZLT Competitors ERAS Competitors TECX Competitors SLDB Competitors ITOS Competitors ETON Competitors ALT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HURA) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TuHURA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TuHURA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
